Cargando…
P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.
Autores principales: | Bhide, Aniket, Chatterjee, Gaurav, Rajpal, Sweta, Joshi, Swapnali, Terse, Vishram, Shetty, Dhanlaxmi, Gokarn, Anant, Punatar, Sachin, Jindal, Nishant, Bagal, Bhausaheb, Nayak, Lingaraj, Jain, Hasmukh, Khattry, Navin, Sengar, Manju, Tembhare, Prashant, Gujral, Sumeet, Subramanian, Papagudi, Patkar, Nikhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429214/ http://dx.doi.org/10.1097/01.HS9.0000968724.09323.c5 |
Ejemplares similares
-
P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
por: Tembhare, Prashant, et al.
Publicado: (2023) -
A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1
por: Patkar, Nikhil, et al.
Publicado: (2019) -
Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia
por: Shetty, Dhanlaxmi, et al.
Publicado: (2021) -
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context
por: Patkar, Nikhil, et al.
Publicado: (2019) -
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
por: Patkar, Nikhil, et al.
Publicado: (2021)